ASCO20 Virtual Scientific Program
Coverage from the virtual 2020 ASCO Virtual Scientific Program, hosted by the American Society of Clinical Oncology, May 29-31, 2020.
Overview of Acute Myeloid Leukemia
A panel of experts in acute myeloid leukemia provide an overview of the disease state and its clinical features.
Nearly half of community pharmacies offer long-term care services and play a critical role in ensuring patients have immediate access to medications in long-term care settings.
The FDA granted an Emergency Use Authorization for the drug in hospitalized patients with severe COVID-19, but the authorization does not take the place of a formal new drug approval process.
The recent analysis studied 400 patients with thoracic cancers who received chemotherapy within 3 months of being diagnosed with COVID-19.
At the 2020 American Society of Clinical Oncology Virtual Scientific Program, researchers presented a recent study that is the largest to date analyzing CLL treatment patterns among VHA patients between 2013 and 2018.
Trastuzumab deruxtecan (T-DXd) (Enhertu) demonstrated strong efficacy in a phase 2 trial for treatment of HER2-positive metastatic breast cancer.
Allison Hanson, PharmD, BCPS, 2019-2020 ISMP International Medication Safety Management Fellow, discusses the value of a pharmacist in supporting and implementing medication safety strategies.
Treatment with avelumab (Bavencio) potentially cured 8 of 15 women in a trial with gestational trophoblastic tumors resistant to single-agent chemotherapy.
Today, we’re celebrating Todd Raehtz, RPh, owner of Grass Lake Community Pharmacy in Grass Lake, Michigan.
The process of becoming certified in itself instills a greater sense of belonging in pharmacy among technicians.
Pharmacy Times® spoke with Jennifer Craig, PharmD, CSP, about the value of the pharmacist in the overall health care continuum.
Oriahnn is the first FDA-approved nonsurgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women
The first step in identifying the appropriate patients with hemophilia for prophylaxis is understanding the breadth of severity.